SAN FRANCISCO, US: TerraVia Holdings Inc (TVIA) said that it has received a generally recognised as safe (GRAS) no questions letter from the US Food and Drug Administration for its algae butter. This response paves the way for commercialization of this revolutionary structuring fat through its joint venture partner, Bunge North America.
Algae butter is a palm-free, non-hydrogenated, vegan solution for bakery, spreads and confectionery applications. It delivers outstanding performance and enhanced sensory experience due to its quick melting feature. It also provides clean taste and can reduce saturated fat by up to 50 percent in most applications.
Algae Butter is exclusive to TerraVia and Bunge. It will be produced by the TerraVia and Bunge joint venture, SB Oils, and marketed in the US by Bunge North America.
“The food industry has been searching for a replacement for palm and hydrogenated vegetable oils that maintain quality, taste and functionality and also meets their rigorous criteria for sustainable sourcing. We believe Algae butter is a game changer for the structuring fats industry in terms of sustainability and nutrition,” said Mark Brooks, senior vice president, TerraVia.
“We are excited to be offering this innovative solution as an additional choice to our foodservice and food processor customers in the US. The potential of the product to meet so many on trend demands has been met with strong levels of interest from a number of our food customers,” added Mark Stavro, senior director of marketing, Bunge North America.
© Worldofchemicals News
Read More: TerraVia’s algae butter receives no questions letter from FDA
No comments:
Post a Comment